152 related articles for article (PubMed ID: 16337317)
1. A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco.
Jiang L; Li Q; Li M; Zhou Z; Wu L; Fan J; Zhang Q; Zhu H; Xu Z
Vaccine; 2006 Jan; 24(2):109-15. PubMed ID: 16337317
[TBL] [Abstract][Full Text] [Related]
2. Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector.
Wu L; Jiang L; Zhou Z; Fan J; Zhang Q; Zhu H; Han Q; Xu Z
Vaccine; 2003 Oct; 21(27-30):4390-8. PubMed ID: 14505922
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of the neutralizing epitope of porcine epidemic diarrhea virus by a tobacco mosaic virus-based vector.
Kang TJ; Kang KH; Kim JA; Kwon TH; Jang YS; Yang MS
Protein Expr Purif; 2004 Nov; 38(1):129-35. PubMed ID: 15477091
[TBL] [Abstract][Full Text] [Related]
4. In Planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system.
Fujiyama K; Saejung W; Yanagihara I; Nakado J; Misaki R; Honda T; Watanabe Y; Seki T
J Biosci Bioeng; 2006 May; 101(5):398-402. PubMed ID: 16781468
[TBL] [Abstract][Full Text] [Related]
5. Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector.
Pérez-Filgueira DM; Brayfield BP; Phiri S; Borca MV; Wood C; Morris TJ
J Virol Methods; 2004 Nov; 121(2):201-8. PubMed ID: 15381357
[TBL] [Abstract][Full Text] [Related]
6. Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides.
Zhang Y; Li J; Pu H; Jin J; Zhang X; Chen M; Wang B; Han C; Yu J; Li D
Plant Biotechnol J; 2010 May; 8(4):506-23. PubMed ID: 20331532
[TBL] [Abstract][Full Text] [Related]
7. An induced hypersensitive-like response limits expression of foreign peptides via a recombinant TMV-based vector in a susceptible tobacco.
Li M; Li P; Song R; Xu Z
PLoS One; 2010 Nov; 5(11):e15087. PubMed ID: 21124743
[TBL] [Abstract][Full Text] [Related]
8. Morphology and stability changes of recombinant TMV particles caused by a cysteine residue in the foreign peptide fused to the coat protein.
Li Q; Jiang L; Li M; Li P; Zhang Q; Song R; Xu Z
J Virol Methods; 2007 Mar; 140(1-2):212-7. PubMed ID: 17140672
[TBL] [Abstract][Full Text] [Related]
9. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.
Wigdorovitz A; Pérez Filgueira DM; Robertson N; Carrillo C; Sadir AM; Morris TJ; Borca MV
Virology; 1999 Nov; 264(1):85-91. PubMed ID: 10544132
[TBL] [Abstract][Full Text] [Related]
10. Propagation of plant viruses in hairy root cultures: a potential method for in vitro production of epitope vaccines and foreign proteins.
Shadwick FS; Doran PM
Biotechnol Bioeng; 2007 Feb; 96(3):570-83. PubMed ID: 16900508
[TBL] [Abstract][Full Text] [Related]
11. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
[TBL] [Abstract][Full Text] [Related]
12. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
[TBL] [Abstract][Full Text] [Related]
13. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
[TBL] [Abstract][Full Text] [Related]
14. Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8* produced in plants using a TMV-based vector.
Pérez Filgueira DM; Mozgovoj M; Wigdorovitz A; Dus Santos MJ; Parreño V; Trono K; Fernandez FM; Carrillo C; Babiuk LA; Morris TJ; Borca MV
Arch Virol; 2004 Dec; 149(12):2337-48. PubMed ID: 15338319
[TBL] [Abstract][Full Text] [Related]
15. Suppression of infectious TMV genomes expressed in young transgenic tobacco plants.
Siddiqui SA; Sarmiento C; Valkonen S; Truve E; Lehto K
Mol Plant Microbe Interact; 2007 Dec; 20(12):1489-94. PubMed ID: 17990956
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the antigenicity of the expression product of fusion antigen epitope genes of FMDV].
Wang DM; Shen WT; Li XY; Zhou P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1048-50. PubMed ID: 18992188
[TBL] [Abstract][Full Text] [Related]
17. Assessment of recombinants that arise from the use of a TMV-based transient expression vector.
Rabindran S; Dawson WO
Virology; 2001 Jun; 284(2):182-9. PubMed ID: 11384218
[TBL] [Abstract][Full Text] [Related]
18. Affinity purification of streptavidin using tobacco mosaic virus particles as purification tags.
Negrouk V; Eisner G; Midha S; Lee HI; Bascomb N; Gleba Y
Anal Biochem; 2004 Oct; 333(2):230-5. PubMed ID: 15450797
[TBL] [Abstract][Full Text] [Related]
19. Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions.
Bendahmane M; Koo M; Karrer E; Beachy RN
J Mol Biol; 1999 Jul; 290(1):9-20. PubMed ID: 10388554
[TBL] [Abstract][Full Text] [Related]
20. A novel two-component Tobacco mosaic virus-based vector system for high-level expression of multiple therapeutic proteins including a human monoclonal antibody in plants.
Roy G; Weisburg S; Rabindran S; Yusibov V
Virology; 2010 Sep; 405(1):93-9. PubMed ID: 20673747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
